subject area of
- A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study Academic Article
- Acid-Suppressive Therapy With Esomeprazole for Relief of Unexplained Chest Pain in Primary Care: A Randomized, Double-Blind, Placebo-Controlled Trial Academic Article
- Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis - results from the maintenance phase of the EXPO study Academic Article
- Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis - results from the EXPO study Academic Article
- Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett’s neoplasia in the AspECT Barrett’s chemoprevention trial pathology audit Academic Article
- Editorial: healing of refractory reflux oesophagitis - an ongoing unmet clinical need Academic Article
- Editorial: towards extended acid suppression - the search continues Academic Article
- Effect on Intragastric pH of a PPI with a Prolonged Plasma Half-Life: Comparison between Tenatoprazole and Esomeprazole on the Duration of Acid Suppression in Healthy Male Volunteers Academic Article
- Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study1 Academic Article
- Esomeprazole 40 mg Once a Day in Patients with Functional Dyspepsia: The Randomized, Placebo-Controlled “ENTER” Trial Academic Article
- Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months Academic Article
- Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial Academic Article
- Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis Academic Article
- In Barrett esophagus, high- vs low-dose esomeprazole improved clinical outcomes; aspirin vs no aspirin did not Academic Article
- Management of reflux esophagitis: does the choice of proton pump inhibitor matter? Academic Article
- Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects Academic Article
- Pharmacologic treatment of GERD: Where we are now, and where are we going? Book
- Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z Academic Article
- Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON) Academic Article
- Rabeprazole extended-release 50 mg compared with esomeprazole 40 mg and rabeprazole delayed release 20 mg Academic Article
- Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire Academic Article
- The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial Academic Article
- The impact of illness in patients with moderate to severe gastro-esophageal reflux disease Academic Article
- The impact of intensifying acid suppression on sleep disturbance related to gastro-oesophageal reflux disease in primary care Academic Article
- The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole. Academic Article
- The pharmacodynamics and pharmacokinetics of S-tenatoprazole-Na 30 mg, 60 mg and 90 mg vs. esomeprazole 40 mg in healthy male subjects Academic Article
- Validation of a symptom diary for patients with gastro-oesophageal reflux disease Academic Article